Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Prince Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	950	802	1,267	-	-	-
Market Cap Growth	-36.72%	-36.72%	-	-	-	-
Enterprise Value	1,308	1,180	1,670	-	-	-
Last Close Price	25.95	21.90	34.68	-	-	-
PE Ratio	-	-	82.75	-	-	-
PS Ratio	1.38	1.16	1.68	-	-	-
PB Ratio	1.32	1.11	1.64	-	-	-
P/TBV Ratio	1.32	1.11	1.64	-	-	-
P/FCF Ratio	33.67	28.42	2827.58	-	-	-
P/OCF Ratio	20.56	17.35	20.27	-	-	-
EV/Sales Ratio	1.90	1.71	2.22	-	-	-
EV/EBITDA Ratio	99.52	259.75	21.99	-	-	-
EV/EBIT Ratio	-	-	64.79	-	-	-
EV/FCF Ratio	46.36	41.83	3728.36	-	-	-
Debt / Equity Ratio	0.64	0.64	0.63	0.80	0.94	0.86
Debt / EBITDA Ratio	35.06	35.06	5.81	4.35	12.80	-
Debt / FCF Ratio	16.33	16.33	1094.55	7.25	409.55	-
Asset Turnover	0.50	0.50	0.56	0.55	0.35	0.25
Inventory Turnover	4.33	4.33	4.11	3.68	2.79	2.29
Quick Ratio	0.94	0.94	1.09	0.76	0.67	0.61
Current Ratio	1.56	1.56	1.85	1.59	1.37	1.14
Return on Equity (ROE)	-7.16%	-7.16%	2.14%	8.18%	-1.37%	-5.49%
Return on Assets (ROA)	-2.24%	-2.24%	1.19%	3.26%	-0.06%	-2.65%
Return on Capital (ROIC)	-2.52%	-2.52%	1.32%	3.60%	-0.06%	-2.82%
Return on Capital Employed (ROCE)	-	-	2.20%	6.10%	-	-
Earnings Yield	-5.64%	-6.68%	1.21%	-	-	-
FCF Yield	2.97%	3.52%	0.03%	-	-	-
Dividend Yield	0.96%	-	0.72%	-	-	-
Payout Ratio	-	-	35.46%	-	-	-
Buyback Yield / Dilution	-0.09%	-0.09%	-9.66%	-0.41%	-1.45%	-2.07%
Total Shareholder Return	0.86%	-0.09%	-8.94%	-0.41%	-1.45%	-2.07%

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.